Skip to main content
Year archive

Bliss GVS Pharma Limited — 2026 filings

All 67 regulatory filings released by Bliss GVS Pharma Limited (BLISSGVS) in 2026, sourced directly from the official regulator.

67 Filings
2026 Period
2026 filings (67)
Filing Released Lang
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Punita Sharma & PACs
Major Shareholding Notification
2026-05-21 English
Copy of Newspaper Publication
Earnings Release FY 2026
2026-05-14 English
Please find enclosed herewith the newspaper publication regarding the publication of Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026.
Interim / Quarterly Report FY 2026
2026-05-14 English
Outcome of Board Meeting
Audit Report / Information
2026-05-12 English
Please find enclosed herewith the re-appointment of Internal Auditor of the Company for the financial year 2026-2027
Regulatory Filings
2026-05-12 English
Change in Management
Regulatory Filings
2026-05-12 English
General Updates
Regulatory Filings
2026-05-12 English
Recommended Final Dividend for the financial year ended March 31, 2026, subject to approval of the shareholders in the forthcoming 41st Annual General Meeting of the Company
Earnings Release FY 2026
2026-05-12 English
Please find enclosed herewith the outcome of Nomination and Remuneration Committee meeting held today i.e. on May 12, 2026, the members has granted 1,80,000 stock options under Bliss GVS ....
Share Issue/Capital Change
2026-05-12 English
General Updates
Regulatory Filings
2026-05-12 English
Please find attached herewith the audited standalone & consolidated financial results for the quarter and year ended March 31, 2026
Regulatory Filings
2026-05-12 English
Outcome of Board Meeting
Regulatory Filings
2026-05-12 English
We would like to inform you that the Board Meeting of the Company was held today i.e. on Tuesday, May 12, 2026, at the registered office of the Company. In pursuance of Regulation 30 and ....
Earnings Release FY 2026
2026-05-12 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2026-05-12 English
Please find enclosed herewith the Scrutinizer''s Report of Postal Ballot alongwith Voting Results.
Declaration of Voting Results & Voting Rights Announcements
2026-05-12 English
Please find enclosed herewith the Disclosure of Voting Results of the Postal Ballot along with Scrutinizer Report.
Declaration of Voting Results & Voting Rights Announcements
2026-05-12 English
Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve 1. The Audited Standalone ....
Regulatory Filings
2026-05-05 English
Copy of Newspaper Publication
Regulatory Filings
2026-04-10 English
Please find enclosed herewith the Newspaper publication regarding the dispatch of the Notice of Postal Ballot and E-voting Information.
Regulatory Filings
2026-04-10 English
Please find enclosed herewith the Postal Ballot Notice regarding the appointment of an Independent Director of the Company.
Regulatory Filings
2026-04-09 English
Shareholders meeting
Proxy Solicitation & Information Statement
2026-04-09 English
Please find enclosed herewith the Intimation regarding the Credit Rating received by the Company from Investment Information and Credit Rating Agency of India Limited (ICRA).
Regulatory Filings
2026-04-08 English
Credit Rating- New
Regulatory Filings
2026-04-08 English
Copy of Newspaper Publication
Regulatory Filings
2026-04-06 English
Please find enclosed herewith the Newspaper Advertisement published on April 04, 2026.
Regulatory Filings
2026-04-06 English
We would like to inform you that, based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has approved and passed the resolutions ....
Regulatory Filings
2026-04-03 English
We would like to inform you that, based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has approved and passed the resolutions ....
Regulatory Filings
2026-04-03 English
Appointment
Regulatory Filings
2026-04-03 English
Appointment
Regulatory Filings
2026-04-03 English
Outcome of Board Meeting
Regulatory Filings
2026-04-03 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-04-02 English
Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31, 2026.
Regulatory Filings
2026-04-02 English
Please find enclosed herewith the Intimation regarding the Closure of Trading Window.
Regulatory Filings
2026-03-31 English
General Updates
Regulatory Filings
2026-02-17 English
Please find enclosed herewith the communication to the shareholders regarding tax deduction on the interim dividend declared on February 10, 2026.
Regulatory Filings
2026-02-17 English
The Company wishes to clarify the news item that appeared in CNBC Awaaz today, i.e. February 13, 2026. Please find attached herewith Clarification Letter.
Regulatory Filings
2026-02-13 English
Rumour Verification - Regulation 30(11)
Regulatory Filings
2026-02-13 English
The Company wishes to clarify the news item that appeared in CNBC Awaaz today, i.e. February 13, 2026. Please find attached herewith the Clarification Letter.
Regulatory Filings
2026-02-13 English
Copy of Newspaper Publication
Regulatory Filings
2026-02-12 English
Appointment
Board/Management Information
2026-02-12 English
Please find attached herewith the Intimation regarding appointment of Senior Management Personnel of the Company.
Regulatory Filings
2026-02-12 English
Please find attached herewith the newspaper publication regarding Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025.
Regulatory Filings
2026-02-12 English
Please find attached herewith the newspaper publication regarding Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025.
Regulatory Filings
2026-02-12 English
Resignation
Regulatory Filings
2026-02-10 English
Resignation
Regulatory Filings
2026-02-10 English
Please find attached the Resignation Letters of Whole Time Directors of the Company.
Regulatory Filings
2026-02-10 English
Record Date
Regulatory Filings
2026-02-10 English
Updates
Regulatory Filings
2026-02-10 English
Updates
Regulatory Filings
2026-02-10 English
Please find enclosed herewith the Intimation regarding Fixation of Record Date for an Interim Dividend for the Financial Year 2025-2026
Regulatory Filings
2026-02-10 English
Please find attached the outcome of the Nomination and Remuneration Committee Meeting held today i.e. February 10, 2026, with regard to the grant of 3,38,000 stock options under Bliss GVS ....
Regulatory Filings
2026-02-10 English
Please find attached the details of KMPs for reporting Disclosure of Material Events to Stock Exchanges.
Regulatory Filings
2026-02-10 English
Please find enclosed herewith the Outcome of the Board Meeting held on February 10, 2026.
Regulatory Filings
2026-02-10 English
Dividend
Regulatory Filings
2026-02-10 English
Outcome of Board Meeting
Regulatory Filings
2026-02-10 English
Dividend
Regulatory Filings
2026-02-10 English
The Board Meeting of Bliss GVS Pharma Limited ('the Company') was held today i.e. Tuesday, February 10, 2026, at the registered office of the Company has considered and approved the following ....
Regulatory Filings
2026-02-10 English
Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve 1. The Unaudited Standalone ....
Regulatory Filings
2026-02-03 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-02-03 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2026-02-03 English
Shareholders meeting
Regulatory Filings
2026-01-30 English
Please find enclosed herewith the Scrutinizer Report alongwith the Voting Results.
Regulatory Filings
2026-01-30 English
Please find enclosed herewith the Voting Result alongwith the Scrutinizer Report.
Regulatory Filings
2026-01-30 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015, we would like to inform you that Bliss GVS International PTE Ltd., Singapore, a wholly owned subsidiary of Bliss GVS Pharma Limited, ....
Regulatory Filings
2026-01-27 English
Updates
Regulatory Filings
2026-01-27 English
Please find enclosed herewith the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025.
Regulatory Filings
2026-01-05 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-01-05 English